All good analysis. There is also (nearing $1m) SaaS revenue and growing as its a % of sales repeating every year and R&D revenue of $8m. Although not repeatable I suspect the last two product upgrades are related to this R&D spend. I assume this will repeat also into FY24.
So I am comfortable with adding in $10m pa for these two sources.
That would make FY24 base as $8m + $10m without any new ann.
I read the note regarding receipts received by 20 Oct as a Q4 revenue item so assume lower carry over figure of $8m per @SpecInvestor view #1
All good analysis. There is also (nearing $1m) SaaS revenue and...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DRO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.95 |
Change
-0.060(2.99%) |
Mkt cap ! $1.486B | |||
| Open | High | Low | Value | Volume |
| $1.97 | $2.00 | $1.89 | $27.90M | 14.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65427 | $1.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.96 | 57000 | 2 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| DRO (ASX) Chart |